Agios Pharmaceuticals | AGIO - EPS Earnings Per Share


Agios Pharmaceuticals reported $-1.09 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -1.09 -1.47 -1.78 Nov/05
FY2026Q2 Jun/2026 -1.69 -1.67 -1.93 Jul/30
FY2026Q1 Mar/2026 -1.69 -1.79 -1.55 Apr/29
FY2025Q4 Dec/2025 -1.86 -1.95 -1.44 Feb/12
FY2025Q3 Sep/2025 -1.78 -1.91 16.22 Oct/30




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Arrowhead Research USD -1.36 0.43 Jun/2026
Astellas Pharma JPY 55.69 23.46 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Daiichi Sankyo JPY 45.5 7.78 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Exelixis USD 0.94 0.03 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026